Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Study finds no evidence that exercise may lower woman’s risk of developing MS

Study finds no evidence that exercise may lower woman’s risk of developing MS

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Tau PET imaging in Alzheimer's disease increases opportunities for developing effective drugs

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

Experimental PET tracer can diagnose concussion-related brain degeneration in living person

Exercise can increase endocannabinoid levels even under chronic sleep loss

Exercise can increase endocannabinoid levels even under chronic sleep loss

Experimental drug may prevent development of multiple sclerosis in mice

Experimental drug may prevent development of multiple sclerosis in mice

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

MR Solutions receives order for cryogen-free 7T simultaneous PET-MR preclinical imaging system

Texas A&M research shows nicotine could help protect the aging brain

Texas A&M research shows nicotine could help protect the aging brain

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

CHOP researchers exploit gene discovery in severe epilepsy to identify precision treatment

Researchers identify genetic switch that may be potential target for Alzheimer's disease

Researchers identify genetic switch that may be potential target for Alzheimer's disease

Study of classical Chinese medical literature finds references similar to Alzheimer's disease

Study of classical Chinese medical literature finds references similar to Alzheimer's disease

Researchers reveal presence of toxic protein aggregates in the human brain

Researchers reveal presence of toxic protein aggregates in the human brain

Alzheimer’s Research UK calls for urgent preparation plan for future access to dementia treatments

Alzheimer’s Research UK calls for urgent preparation plan for future access to dementia treatments

Women, minorities less likely to receive stroke treatment, study finds

Women, minorities less likely to receive stroke treatment, study finds

Wayne State receives NIH funding to advance brain aging research

Wayne State receives NIH funding to advance brain aging research

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

Mood stabilizers may decrease negative symptoms in psychiatric patients with specific genotype

Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

Americans believe cancer to be major health care challenge, Mayo Clinic survey reveals

Online articles about preventing Alzheimer's disease offer poor advice, research finds

Online articles about preventing Alzheimer's disease offer poor advice, research finds

Memory loss symptoms not sufficient to diagnose other forms of Alzheimer's

Memory loss symptoms not sufficient to diagnose other forms of Alzheimer's

Moderately vigorous physical activity in midlife linked to better cognition at old age

Moderately vigorous physical activity in midlife linked to better cognition at old age

International conference on longevity to be held in Brussels for 3 days

International conference on longevity to be held in Brussels for 3 days

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.